Over the past two decades, global patterns in tobacco production and trade have shifted dramatically. Considerable research has gone into detailing these shifts, elucidating their drivers, and understanding their implications for tobacco control. One area of research that remains relatively unexplored, however, is how these changes have altered the global flow of tobacco and the […]

Globally, healthcare products are often developed without taking into consideration sex- and gender-based physiological and psychological differences. Male domination in science, medicine, and technology has led to the overrepresentation of men in clinical trials, a lack of gender-specific medical guidelines, and limited innovation in health-related technologies tailored to women’s needs. The impact of these oversights […]

The Foundation recently consulted with external experts from the fields of HIV and drug harm reduction to learn how they were able to tilt the needle away from moral panic, toward evidence-informed policies. Drawing on decades of experience, they told us that success requires a concerted effort to harness not just data, but emotion and […]

The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) was negotiated and adopted to decrease the burden caused by smoking both on the health and economies of the countries most affected. The smokers, users of tobacco, and tobacco growers remained at the heart of discussions and, therefore, the FCTC encompassed both demand and […]

In the 1950s, if you asked a smoker why he or she smoked, they would not have replied, “because I am hopelessly addicted.” More likely, they would have told you about the pleasure they experienced from smoking. Today, we know something they did not. Smoking kills. Worldwide, 1.1 billion people smoke, causing more than 7 million deaths each year. […]